Domain Therapeutics
Edit

Domain Therapeutics

http://domaintherapeutics.com/
Last activity: 28.07.2023
Categories: HealthTechDrugDevelopmentClinicBioTechResearchMedtechManufacturingIT
[EN] Domain Therapeutics is a biopharmaceutical company dedicated to the discovery and development of new drug candidates targeting G Protein-Coupled Receptors(GPCRs), one of the most important classes of drug targets. With teams at work in France and Canada, Domain operates multiple technologies aimed at validating targets and discovering first-in-class therapies (small molecules or antibodies). It creates a pipeline of high-value programs in immuno-oncology, neurology and rare diseases which are developed as proprietary programs up to early clinical phases or in collaboration with pharma partners. [FR] Domain Therapeutics est une société biopharmaceutique dédiée à la découverte et au développement de nouveaux candidats médicaments ciblant les récepteurs couplés aux protéines G (GPCR), l'une des classes de cibles médicamenteuses les plus importantes. Avec des équipes basées en France et au Canada, Domain exploite de multiples technologies visant à valider des cibles et à découvrir des thérapies de premier ordre (petites molécules ou anticorps), crée un pipeline de programmes de forte valeur ajoutée en immuno-oncologie, neurologie et maladies rares, développés seuls jusqu'aux premières phases cliniques ou en collaboration avec des partenaires pharmaceutiques.
Likes
53
Followers
360
Followers
5.06K
Mentions
11
Location: France, Grand Est, Illkirch-Graffenstaden
Employees: 51-200
Phone: +33 3 90 40 61 52
Total raised: $55.27M
Founded date: 2008

Investors 5

Funding Rounds 5

DateSeriesAmountInvestors
23.05.2022Series A$42MadMare Bio...
13.01.2020-$6.68M-
28.05.2019-$3.91M-
14.04.2014Grant$230K-
17.07.2012-$2.45M-

Mentions in press and media 11

DateTitleDescriptionSource
28.07.2023Latest Updates of 7 Viva's Portfolio CompaniesHONG KONG, July 28, 2023 /PRNewswire/ -- In the face of ever-changing circumstances, technological i...en.prnasia...
27.07.2022Portfolio Highlights: Clinical and Financing Updates of AIxp...SHANGHAI, China, July 27, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva BioI...en.prnasia...
26.05.2022Portfolio Highlights: Clinical and Financing Updates of Anji...SHANGHAI, May 26, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnovator...en.prnasia...
10.05.2022Domain Therapeutics Raises $42M in Series A FinancingDomain Therapeutics, a Strasbourg, France- and Montreal, Canada-based biopharmaceutical company spec...finsmes.co...
10.05.2022adMare BioInnovations joins a $42m Series A financing in Dom...Strasbourg, France – Montreal, Canada – May 10, 2022 – Domain Therapeutics, a biopharmaceutical comp...admarebio....
08.06.2020Find Therapeutics, a new drug development company dedicated ...The new company raises initial capital to develop transmembrane peptides against GPCRs to address hi...admarebio....
13.01.2020Domain Therapeutics Secures €6M in Debt FinancingDomain Therapeutics, a Strasbourg, France-based biopharmaceutical company, closed a €6m ($6.7M) debt...finsmes.co...
28.05.2019Domain Therapeutics Raises €3.5M in FundingDomain Therapeutics, a Strasbourg, France-based biopharma company, secured €3.5M ($3.9M) in funding....finsmes.co...
28.05.2019Term Sheet — Tuesday May 28A TALE OF MANY MANY MERGERS Hello again, Term Sheet readers! I hope y’all had a grill-filled Memori...fortune.co...
14.04.2014Domain Therapeutics Receives $230K Second Grant from Michael...Domain Therapeutics, a Strasbourg, France- and Montreal, Canada-based biopharmaceutical company dedi...finsmes.co...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In